Looks like the news may already have been priced in.

Typically these stocks surge on news, then sag until the next news item. Given that the clinical trials will take a VERY long time (by day-traders' standards) we will probably see some sagging and surging..... sigh.

Takes a strong stomach to invest in biotechs.